Is Sotorasib included in the scope of medical insurance reimbursement?

As of now, Sotorasib (Sotorasib) has not been officially launched in mainland China, so it has not yet been included in the scope of national medical insurance reimbursement. This means that domestic patients cannot purchase Sotorasibu directly through hospitals or regular pharmacies, nor can they get reimbursement through medical insurance. For patients who are in urgent need of treatment with this drug, this will undoubtedly bring certain difficulty in obtaining it and financial pressure.

Nonetheless, some patients will choose to obtain sotoraxib through overseas channels. Currently, original research drugs that have been launched in overseas markets mainly come from Europe and Hong Kong, China, and their prices are generally high, often exceeding tens of thousands of yuan. Moreover, due to the influence of supply channels, logistics, customs clearance and other factors, the overall cost and cycle of drug purchase also require patients and their families to make adequate plans in advance.

Compared with original drugs, generic versions of drugs in some countries and regions are more affordable. For example, the current market price of imitation Sothoracib produced by two companies, Lucius (Lusun) and Daxiong (Bear), is After significant reduction, the price of 120 mg × 56 tablets is approximately RMB 1,000, which greatly reduces the economic burden of long-term medication for patients. According to existing data, these generic drugs are consistent with the original drugs in terms of ingredients and dosage, and some patients report that the curative effects are basically similar.

In general, although sotorasibu is not currently available in the country or included in medical insurance, patients can still obtain the drug through legal and safe overseas channels and choose a suitable version according to their economic status. While waiting for national approval and progress in medical insurance negotiations, patients in need should use drugs under the guidance of professional doctors and weigh the medication plan based on their own conditions to ensure a balance between efficacy and safety.

Reference materials:https://www.drugs.com/